Logo image of HBI

HANESBRANDS INC (HBI) Stock Fundamental Analysis

NYSE:HBI - New York Stock Exchange, Inc. - US4103451021 - Common Stock - Currency: USD

4.84  +0.19 (+4.09%)

After market: 4.89 +0.05 (+1.03%)

Fundamental Rating

3

Taking everything into account, HBI scores 3 out of 10 in our fundamental rating. HBI was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. HBI may be in some trouble as it scores bad on both profitability and health. HBI scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year HBI was profitable.
HBI had a positive operating cash flow in the past year.
HBI had negative earnings in 4 of the past 5 years.
Of the past 5 years HBI 4 years had a positive operating cash flow.
HBI Yearly Net Income VS EBIT VS OCF VS FCFHBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

With a Return On Assets value of -7.61%, HBI is not doing good in the industry: 68.00% of the companies in the same industry are doing better.
HBI's Return On Equity of -669.26% is on the low side compared to the rest of the industry. HBI is outperformed by 88.00% of its industry peers.
HBI's Return On Invested Capital of 12.87% is fine compared to the rest of the industry. HBI outperforms 80.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HBI is in line with the industry average of 10.82%.
The 3 year average ROIC (9.25%) for HBI is below the current ROIC(12.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -7.61%
ROE -669.26%
ROIC 12.87%
ROA(3y)-3.54%
ROA(5y)-2.1%
ROE(3y)-326.11%
ROE(5y)-195.33%
ROIC(3y)9.25%
ROIC(5y)10.86%
HBI Yearly ROA, ROE, ROICHBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

HBI has a Operating Margin of 12.67%. This is amongst the best in the industry. HBI outperforms 82.00% of its industry peers.
In the last couple of years the Operating Margin of HBI has declined.
Looking at the Gross Margin, with a value of 41.77%, HBI is doing worse than 66.00% of the companies in the same industry.
HBI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.67%
PM (TTM) N/A
GM 41.77%
OM growth 3Y-4.92%
OM growth 5Y-3.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.34%
HBI Yearly Profit, Operating, Gross MarginsHBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

HBI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
HBI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HBI has been reduced compared to 5 years ago.
The debt/assets ratio for HBI is higher compared to a year ago.
HBI Yearly Shares OutstandingHBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
HBI Yearly Total Debt VS Total AssetsHBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 1.84 indicates that HBI is not a great score, but indicates only limited risk for bankruptcy at the moment.
HBI has a worse Altman-Z score (1.84) than 74.00% of its industry peers.
HBI has a debt to FCF ratio of 23.24. This is a negative value and a sign of low solvency as HBI would need 23.24 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 23.24, HBI is doing worse than 62.00% of the companies in the same industry.
A Debt/Equity ratio of 53.45 is on the high side and indicates that HBI has dependencies on debt financing.
HBI has a Debt to Equity ratio of 53.45. This is amonst the worse of the industry: HBI underperforms 92.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 53.45
Debt/FCF 23.24
Altman-Z 1.84
ROIC/WACC1.28
WACC10.04%
HBI Yearly LT Debt VS Equity VS FCFHBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.55 indicates that HBI should not have too much problems paying its short term obligations.
HBI has a worse Current ratio (1.55) than 66.00% of its industry peers.
HBI has a Quick Ratio of 1.55. This is a bad value and indicates that HBI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HBI (0.67) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.67
HBI Yearly Current Assets VS Current LiabilitesHBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

4

3. Growth

3.1 Past

HBI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 142.31%, which is quite impressive.
Measured over the past years, HBI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -23.96% on average per year.
The Revenue has decreased by -3.63% in the past year.
The Revenue for HBI have been decreasing by -11.40% on average. This is quite bad
EPS 1Y (TTM)142.31%
EPS 3Y-37.35%
EPS 5Y-23.96%
EPS Q2Q%60%
Revenue 1Y (TTM)-3.63%
Revenue growth 3Y-19.81%
Revenue growth 5Y-11.4%
Sales Q2Q%-0.41%

3.2 Future

The Earnings Per Share is expected to grow by 14.58% on average over the next years. This is quite good.
Based on estimates for the next years, HBI will show a small growth in Revenue. The Revenue will grow by 0.87% on average per year.
EPS Next Y21.72%
EPS Next 2Y15.11%
EPS Next 3Y13.68%
EPS Next 5Y14.58%
Revenue Next Year-3.37%
Revenue Next 2Y-1.97%
Revenue Next 3Y-1.03%
Revenue Next 5Y0.87%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HBI Yearly Revenue VS EstimatesHBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
HBI Yearly EPS VS EstimatesHBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.68, which indicates a rather cheap valuation of HBI.
86.00% of the companies in the same industry are more expensive than HBI, based on the Price/Earnings ratio.
HBI is valuated cheaply when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 8.12, the valuation of HBI can be described as reasonable.
Based on the Price/Forward Earnings ratio, HBI is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
HBI is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.09, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.68
Fwd PE 8.12
HBI Price Earnings VS Forward Price EarningsHBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HBI indicates a somewhat cheap valuation: HBI is cheaper than 64.00% of the companies listed in the same industry.
HBI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. HBI is cheaper than 68.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.94
EV/EBITDA 7.47
HBI Per share dataHBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5

4.3 Compensation for Growth

HBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HBI's earnings are expected to grow with 13.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y15.11%
EPS Next 3Y13.68%

More info and screens

0

5. Dividend

5.1 Amount

HBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HANESBRANDS INC

NYSE:HBI (8/8/2025, 8:04:00 PM)

After market: 4.89 +0.05 (+1.03%)

4.84

+0.19 (+4.09%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners93.15%
Inst Owner Change-0.22%
Ins Owners1.12%
Ins Owner Change7.03%
Market Cap1.71B
Analysts50.77
Price Target5.36 (10.74%)
Short Float %10.78%
Short Ratio8.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)117.65%
Min EPS beat(2)17.38%
Max EPS beat(2)217.92%
EPS beat(4)4
Avg EPS beat(4)78.8%
Min EPS beat(4)17.38%
Max EPS beat(4)217.92%
EPS beat(8)6
Avg EPS beat(8)45.62%
EPS beat(12)8
Avg EPS beat(12)30.73%
EPS beat(16)11
Avg EPS beat(16)26.04%
Revenue beat(2)1
Avg Revenue beat(2)-3.69%
Min Revenue beat(2)-7.43%
Max Revenue beat(2)0.05%
Revenue beat(4)1
Avg Revenue beat(4)-10.83%
Min Revenue beat(4)-27.34%
Max Revenue beat(4)0.05%
Revenue beat(8)1
Avg Revenue beat(8)-7.24%
Revenue beat(12)2
Avg Revenue beat(12)-5.92%
Revenue beat(16)4
Avg Revenue beat(16)-3.95%
PT rev (1m)-2.65%
PT rev (3m)7.29%
EPS NQ rev (1m)-0.45%
EPS NQ rev (3m)-9.09%
EPS NY rev (1m)0%
EPS NY rev (3m)4.33%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.26%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 7.68
Fwd PE 8.12
P/S 0.49
P/FCF 16.94
P/OCF 13.18
P/B 39.4
P/tB N/A
EV/EBITDA 7.47
EPS(TTM)0.63
EY13.02%
EPS(NY)0.6
Fwd EY12.32%
FCF(TTM)0.29
FCFY5.9%
OCF(TTM)0.37
OCFY7.59%
SpS9.87
BVpS0.12
TBVpS-4.2
PEG (NY)0.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.61%
ROE -669.26%
ROCE 16.29%
ROIC 12.87%
ROICexc 13.76%
ROICexgc 34.66%
OM 12.67%
PM (TTM) N/A
GM 41.77%
FCFM 2.89%
ROA(3y)-3.54%
ROA(5y)-2.1%
ROE(3y)-326.11%
ROE(5y)-195.33%
ROIC(3y)9.25%
ROIC(5y)10.86%
ROICexc(3y)9.89%
ROICexc(5y)12.07%
ROICexgc(3y)24.54%
ROICexgc(5y)28.18%
ROCE(3y)11.7%
ROCE(5y)13.75%
ROICexcg growth 3Y-1.22%
ROICexcg growth 5Y5.88%
ROICexc growth 3Y-7.77%
ROICexc growth 5Y0.09%
OM growth 3Y-4.92%
OM growth 5Y-3.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.34%
F-Score4
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 53.45
Debt/FCF 23.24
Debt/EBITDA 4.46
Cap/Depr 37.03%
Cap/Sales 0.83%
Interest Coverage 250
Cash Conversion 24.97%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 0.67
Altman-Z 1.84
F-Score4
WACC10.04%
ROIC/WACC1.28
Cap/Depr(3y)95.15%
Cap/Depr(5y)77.33%
Cap/Sales(3y)1.91%
Cap/Sales(5y)1.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)142.31%
EPS 3Y-37.35%
EPS 5Y-23.96%
EPS Q2Q%60%
EPS Next Y21.72%
EPS Next 2Y15.11%
EPS Next 3Y13.68%
EPS Next 5Y14.58%
Revenue 1Y (TTM)-3.63%
Revenue growth 3Y-19.81%
Revenue growth 5Y-11.4%
Sales Q2Q%-0.41%
Revenue Next Year-3.37%
Revenue Next 2Y-1.97%
Revenue Next 3Y-1.03%
Revenue Next 5Y0.87%
EBIT growth 1Y11.81%
EBIT growth 3Y-23.76%
EBIT growth 5Y-14.59%
EBIT Next Year26.31%
EBIT Next 3Y9.48%
EBIT Next 5Y8.73%
FCF growth 1Y133.33%
FCF growth 3Y-25.8%
FCF growth 5Y-20.26%
OCF growth 1Y256.3%
OCF growth 3Y-24.88%
OCF growth 5Y-19.94%